BACKGROUND: Decisions to screen older patients for cancer are complicated by the fact that aging populations are heterogeneous with respect to life expectancy.
DESIGN AND PARTICIPANTS:
Cross-sectional data from the 1993, 1998, 2000, and 2005 National Health Interview Surveys (NHIS) were used to examine trends in screening for women age 35-64 and 65+ years of age. We investigated whether health is associated with Pap testing among older women using the 2005 NHIS (N= 3,073). We excluded women with a history of cervical cancer or who had their last Pap because of a problem.
MEASUREMENTS:
The dependent variable was having a Pap test within the past 3 years. Independent variables included three measures of respondent health (the Charlson comorbidity index (CCI), general health status and having a chronic disability), hysterectomy status and sociodemographic factors.
MAIN RESULTS: NHIS data showed a consistent pattern of lower Pap use among older women (65+) compared to younger women regardless of hysterectomy status. Screening also was lower among older women who reported being in fair/poor health, having a chronic disability, or a higher CCI score (4+). Multivariate models showed that over 50% of older women reporting poor health status or a chronic disability and 47% with a hysterectomy still had a recent Pap.
CONCLUSIONS:
Though age, health and hysterectomy status appear to influence Pap test use, current national data suggest that there still may be overutilization and inappropriate screening of older women.
INTRODUCTION
Decisions to screen older patients for cancer often are complicated by the fact that aging populations are heterogeneous with respect to life expectancy. As life expectancy decreases with age and worsening health, so does the probability that a patient will benefit from early detection. 1 However, if life expectancy is long, healthy older adults may continue to benefit from screening. Walter and Covinsky suggest that it may be more useful for clinicians to consider patient characteristics and preferences than simply using age to guide screening decisions in older patients. 2 Recently, several professional organizations have updated their clinical guidelines to recommend an age at which older women (defined as 65 or 70 years of age depending on the organization) who have had adequate recent screening with no abnormal Pap test results may discontinue cervical cancer screening. 3 , 4 Inclusion of an upper age limit in clinical guidelines is a result of growing evidence suggesting that the benefits of early detection (i.e., prolonged life and reduced disease-specific mortality) are not likely to be realized by older women at low risk for cervical cancer. Furthermore, the potential harms associated with screening, such as falsepositive results, anxiety and invasive follow-up procedures, are thought to outweigh the benefits among older women with a history of normal screening tests because they are at low risk. 3 Recent data from the Women's Health Initiative suggest that sexually-active older women who are not married or living with a partner may benefit from continued screening because of the increased chance for new exposure to human papillomavirus. 5 Regardless of age, routine screening is considered unnecessary for women who have had a total hysterectomy for benign disease. 3 Although cervical cancer screening guidelines recommend an upper age limit for women with a history of normal test results, variability in the life expectancy of older adults may render decisions about whether to continue screening difficult for low risk women. Lower rates of screening have been associated with increasing age, lack of contact with a primary care provider, not having a usual source of health care, low income, low educational attainment and being unmarried. 6, 7 Self-reported health status also has been correlated with screening use. In one study, younger women (ages 25-64) reporting excellent/very good health status were significantly more likely to report recent Pap use than those with poorer health status, but the same association between health status and screening was not found among older women (65+ years). 6 In addition to self-reported health status, other measures of life expectancy, such as the presence of comorbid conditions and disability, have been correlated with cancer screening. For example, some studies have found that screening rates decreased with increasing comorbidity, 8, 9 but a study by Mandelblatt et al. 10 found that older women with more than three chronic illnesses were twice as likely to get screened as women with fewer illnesses-perhaps because they had more opportunities to do so. In this analysis, we examined whether the changes in clinical guidelines regarding older age are reflected in national screening rates and whether older women's life expectancy influenced these rates. We first updated prior reports of national trends 11 by describing Pap test rates stratified by age and hysterectomy status before and after guidelines were revised. We then explored whether and how life expectancy and hysterectomy status were associated with Pap use. Because there is no generally accepted way to measure life expectancy in national surveys, we tested models using three different measures of health available on the National Health Interview Survey (NHIS): the Charlson comorbidity index (CCI), general health status, and chronic disability. To our knowledge, this is the first attempt to capture health and comorbidity as a factor influencing Pap screening among older women in a nationally representative dataset. Given current guidelines and known correlates of Pap test use, we expected screening to be lower among older women in poor health and those who had undergone a hysterectomy.
METHODS
We analyzed data from the NHIS which is the leading source of health information on the U.S. civilian, noninstitutionalized population. 12 An annual, in-person household survey, it collects demographic and health information using a complex, stratified, multistage sample designed to provide nationally representative data. The NHIS oversamples Hispanics and African Americans to improve their estimates. 15 The extensive literature demonstrating an association between these factors and cancer screening, and their availability in the NHIS dataset, facilitated our selection of covariates.
Independent Variables
We organized covariates used into four groups: health, hysterectomy status, health care access, and demographics.
Health. We explored three different measures available on the NHIS to capture respondent health as a proxy for life expectancy: the CCI, 17 general health status (excellent/good and fair/poor) and having a chronic disability (yes/no). We calculated a CCI with values ranging from 0-17 and used the following medical conditions: myocardial infarction, cerebrovascular disease, chronic pulmonary disease, ulcer disease, cancer, diabetes, renal disease, liver disease, connective tissue disease, and dementia. Based on the distribution of responses in the NHIS 2005, we created a categorical variable (0, 1-3, 4+, and missing). The CCI, one of the most commonly used comorbidity indices in the field of health services research, is a good predictor of mortality [17] [18] [19] and has been validated in many different settings. [20] [21] [22] Selfreported CCI's predicted 1-year mortality comparably with indices based on administrative data. 23 Hysterectomy Status. Respondents self-reported hysterectomy status (yes/no).
Health Care Access. Access to health care was measured by whether respondents had health insurance coverage (private, public or no health insurance) and a usual source of health care (yes/no). Health care utilization was measured by whether respondents had visited a doctor or OB/GYN in the last year. Health behaviors associated with Pap testing included having a mammogram within the past two years (yes/no) and smoking status (never/former/current).
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Sociodemographics. Demographic measures included age, race/ethnicity (Hispanic, non-Hispanic white, non-Hispanic black), immigration status (born in U.S., in U.S. <10 years and in U.S. 10+ years), marital status (married/living with partner and not married), educational attainment (less than high school, high school graduate, some college, college graduate) and annual household income (<$20k, $20k -$34, 999, $35k -$54,999, $55k -$74,999 and $75k and over).
STATISTICAL ANALYSIS
We computed frequencies and regressions using SUDAAN 9.01 software 27 , because it takes into account NHIS's complex sample design. First, we examined trends in screening by hysterectomy status for women age 35-64 and 65+ years using NHIS data from 1993 (N=5,405 and N=2,655, respectively), 1998 (N=8,421 and N=3,594, respectively), 2000 (N=8,361 and N=3,458, respectively), and 2005 (N=8,158 and N=3,148, respectively). Data comparing trends by year were standard-ized to the 2000 population using 5-year age groups. We limited our analysis to years in which respondents were asked to report both whether they had had a hysterectomy and a Pap. While all these samples excluded respondents with a history of cervical cancer, not all of them were asked about the reason for the last Pap (i.e., routine or for a specific problem). However, the 2005 sample did make this distinction. Therefore, in the next phase of the analysis investigating whether health and hysterectomy status were associated with recent screening among older women, we excluded 75 NHIS 2005 respondents who had their most recent Pap due to a specific problem (i.e., sample size reduced from 3,148 to 3,073).
To address whether health and hysterectomy status were associated with a recent Pap among older women, we investigated univariate associations by computing weighted percentages and 95% confidence intervals. Next, we conducted multivariate logistic regression analyses controlling for known correlates. Because the CCI, general health status and chronic disability are correlated and measure similar constructs, we ran three separate models. Independent variables that did not show significant variation with the outcome, had a sample size <50 in a given stratum or were temporally inconsistent with the outcome variable (e.g., doctor's visit in the last year vs. 3 years) were not included in the final models. From the odds ratios of the logistic models, we computed adjusted proportions called predicted marginals for each category of an independent variable. 28 This method standardizes measures to adjust for covariates and can be interpreted like percentages. Predicted marginals have intuitive appeal because they make it easier for readers to assess the prevalence of sample in each category. Screening declined with increasing age (from 72% in women 65-69 years to 40% in women 80+). Lower screening rates were reported by women who had lower educational attainment, lower household income or were not married. Women with no recent Pap also were less likely to have had private health coverage, a usual source of healthcare, a recent healthcare visit, or a recent mammogram. Current smokers had lower rates than former or never smokers, though these results were not statistically significant. Women who reported a hysterectomy, fair/poor health, a chronic disability, or a higher CCI score (4+) also were less likely to report a recent test.
RESULTS

Figure 1 displays
Knowing that the three health measures (CCI, general health status and chronic disability) available on the NHIS are correlated with each other and are imprecise indicators of life expectancy, we tested each separately to see how they performed in multivariate regression models. Each of the three models reported in Table 2 adjusted for age, education, marital status, race/ethnicity, health insurance coverage, and recent mammogram use. The CCI was included in the first model (column 1), while general health status (column 2) and chronic disability (column 3) were included in the second and third models, respectively. Recent screening was associated with reports of being in excellent/good health and no chronic disabilities. Although the negative association between screening and CCI was consistent with the other two health measures, it was not statistically significant even when the index was modeled as a binary variable (data not shown).
In all three models, hysterectomy status showed a significant negative association with screening (Table 2 ). About 47% of women with a hysterectomy had a recent Pap test compared with approximately 62% of women with no hysterectomy (p= 0.0000). Patterns of association between screening and the adjusted covariates (age, education, marital status, race/ ethnicity, and recent mammogram use) were the same in all models as described in Table 2 . The exception was health insurance coverage. Health insurance coverage was not significant in any of the models, but was retained for conceptual reasons, because it is an indicator of health care access that has been highly correlated with cancer screening in U.S. populations.
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CONCLUSIONS
Our study provides the most recent data showing that national rates of cervical cancer screening are continuing to decline in The data suggest that screening rates are lower for older women in poorer health (e.g., 57.2% with a recent Pap among women reporting excellent/good health compared to 52.5% of women in fair/poor health, p=0.03). Still, over half of women reporting poor health, a chronic disability, or a CCI of 4 or greater reported a recent Pap test. This finding indicates overutilization of screening among women who are unlikely to benefit from early detection. Our results are similar to findings from a 2000-2001 study conducted in California that showed overutilization of breast and cervical cancer screening among older women in poor health. 1 It is unclear why women who seemingly won't benefit from continued Pap testing still get screened. Some investigators have suggested that older women in poor health may be more motivated to get screened because of a greater sense of susceptibility to illness. They also may have more opportunities to screen because of frequent interactions with healthcare providers. 31 Another possibility is that decisions to discontinue screening would involve a conversation between clinicians and patients about predicting life expectancy and there are no specific clinical guidelines on how to do this. Further, older adults may not understand concepts of uncertainty and probability that underlie understanding how competing causes of mortality and delayed benefits of screening influence the prudence of continued screening.
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A national survey of women 40 and older found that women were resistant to reducing the frequency of Pap tests as recommended by revised clinical guidelines especially if they thought a reduction was being suggested for cost rather than scientific reasons. 33 Similarly, a qualitative study of attitudes about continuing cancer screening found that 43% of older adults would consider screening even if their doctor recommended against it. 32 It is not clear whether these participants understood that the benefits of screening may not be realized for years or whether having this knowledge would make a difference in their enthusiasm for screening. Although patient preferences are important to consider, there is some evidence that physicians also account for patient health status in deciding whether to test, 34 and our data support this.
Although recent Pap use was lower among all women who reported hysterectomies during the time period we examined (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) , about half of older women with hysterectomies were screened within the three years prior to interview in 2005. Since we excluded women with a history of cervical cancer from our analysis, the women with a hysterectomy in our sample likely had the procedure for benign disease, suggesting that Pap testing was unnecessary. Our findings are not inconsistent with Behavioral Risk Factor Surveillance System data from 1999 to 2002 that showed more than two-thirds of hysterectomized women reported a recent Pap (a higher rate of inappropriate screening compared to our data). 35 More of a decline might have been expected in our 2005 study both because the USPSTF recommended in 1996 that Pap testing is unnecessary for women who had a hysterectomy with removal of the cervix for benign disease and because of the considerable publicity generated by the earlier study. We examined three different health indicators. Both poorer general health and chronic disability were independently associated with declining Pap use. Although the CCI did not reach statistical significance in our multivariate analysis, the pattern of association was consistent with the other two measures. Our findings for general health status are consistent with Walter and colleagues. 1 With regards to chronic disability, research has shown that women with major lower extremity mobility difficulties are less likely to receive Pap tests. 36 We could not ascertain this distinction with the NHIS data.
For a woman with short life expectancy, it would be clinically appropriate to forego cancer screening. Thus, the lower rate of screening among women with poor health status in our sample most likely represents a responsible population pattern. However, the lower screening rate among women with disabilities should be viewed with more caution. In our analysis, we could not distinguish whether the specific disability would reduce life expectancy. If it would not, then cancer screening would still be appropriate. Clinicians and health care systems need to facilitate access to cancer screening among disabled women with good life expectancy. The lack of a significant association between the CCI and screening may mean that clinicians do not pay attention to life expectancy or medical disease burden when deciding whether to perform cervical cancer screening, or the CCI, which was originally created to predict mortality, may not be as sensitive in detecting an association with health care utilization as the other two health measures. An earlier study using NHIS found that the CCI was significantly associated with PSA testing among men aged 45-74 (1.09, CI=1-1.18, p=.041) but not among older men (75+). 37 It should be noted that, in this analysis, the CCI was adapted to the content of the NHIS and has not been previously validated with this particular survey instrument; however, the adapted index used here was a fairly close approximation of other claims-based applications. 38 Although we used data from a large, nationally representative sample with high response rates to assess the association between age, health and hysterectomy status and cervical cancer screening, there are some limitations. Because the NHIS is cross-sectional, we cannot ascertain causality. Thus we cannot conclude that health status is the reason older women are getting fewer Pap tests. Nor can we conclude that revised clinical guidelines recommending longer screening intervals led to discontinuing screening at older ages or caused the decline in Pap use that we observed between 2000 and 2005. Furthermore, self-reported data could overestimate adherence. 39 We could not assess the proportion of hysterectomies that were supracervical or performed for cervical neoplasia with our data. Nevertheless, prior national estimates [40] [41] [42] have historically focused on the challenge of increasing delivery and uptake of recommended clinical practices. However, evidence of widespread overutilization here and elsewhere in health care, 43, 44 suggests that more theoretic research on the factors that influence and explain overuse of health services is needed. Models have been applied to the overuse of antibiotics 45 and diagnostic tests 46, 47 and extending similar efforts to understand individual, provider and system factors that encourage overutilization of screening would benefit both patients and society by avoiding tests that produce unnecessary risks and costs.
Informed decision making approaches, such as decision aids, could potentially reduce unnecessary Pap testing. For example, decision aids for prostate cancer screening have resulted in decreased interest in and use of PSA testing among patients seeking routine care. 48 Yet informed decision-making approaches would be incomplete without incorporating information regarding life expectancy, the relevance of competing disease risks, and the delayed medical benefit of screening. Sometimes the ascertainment of unnecessary testing will be clear-cut, as in the case of women with a prior hysterectomy, and informational interventions will be relatively straightforward. Yet in more difficult cases, such as among women with advancing age or competing illnesses, informed decisionmaking approaches that help patients and clinicians better communicate about how these complex issues relate to cervical cancer screening will be beneficial.
